2016
DOI: 10.1186/s12944-016-0305-5
|View full text |Cite
|
Sign up to set email alerts
|

Effects of different fatty acids composition of phosphatidylcholine on brain function of dementia mice induced by scopolamine

Abstract: BackgroundPhosphatidylcholine (PC), the major source of dietary choline, has been demonstrated to improve the capability of learning and memory in rodent and the amelioration of long-chain n-3 polyunsaturated fatty acids (PUFA) on anti-aging and anti-oxidation is widely known as well. In this study, three kinds of PC were chose to demonstrate the role of different fatty acids composition on glycerol backbone in improving the brain function of mice induced by scopolamine which was used to impair cholinergic sys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
30
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 50 publications
(30 citation statements)
references
References 51 publications
0
30
0
Order By: Relevance
“…A previous study showed that garlic extracts effect Aβ-induced cytoxicity in neuron-like PC12 cells (Zhou et al, 2016); however, in this study, oxidative and cholinergic effects were not investigated. The scopolamine-induced mouse model was used in the present study because it is a well-known animal model of experimental Alzheimer’s disease (Kim et al, 2012) and provides a good and relevant example of cholinergic dysfunction; scopolamine induces memory impairment, decreases the activities of anti-oxidative enzymes such as GPx, and increases levels of lipid peroxidant, MDA, in the brain (Budzynska et al, 2015).…”
Section: Discussionmentioning
confidence: 85%
“…A previous study showed that garlic extracts effect Aβ-induced cytoxicity in neuron-like PC12 cells (Zhou et al, 2016); however, in this study, oxidative and cholinergic effects were not investigated. The scopolamine-induced mouse model was used in the present study because it is a well-known animal model of experimental Alzheimer’s disease (Kim et al, 2012) and provides a good and relevant example of cholinergic dysfunction; scopolamine induces memory impairment, decreases the activities of anti-oxidative enzymes such as GPx, and increases levels of lipid peroxidant, MDA, in the brain (Budzynska et al, 2015).…”
Section: Discussionmentioning
confidence: 85%
“…In the aged human, the plasma level of phosphatidylcholine was positively correlated with cognitive flexibility within the prefrontal cortex and the decreased plasma level of phosphatidylcholine was observed in Alzheimer's disease (AD) patients [20]. Dietary supplementation with phosphatidylcholine improved brain function, such as learning and memory, and conferred increased resistance to oxidative stress by modulating the activity of SOD in mice [21]. In rat adrenal pheochromocytoma cells, treatment with phosphatidylcholine hydroperoxides enhanced the activities of antioxidant genes, including CAT, SOD, and glutathione peroxidase [22].…”
Section: Introductionmentioning
confidence: 99%
“…Scopolamine (SCO), a non-selective muscarinic acetylcholine receptor antagonist, is known to interfere with cholinergic transmission in the brain ( 1 , 2 ). Recently, we have reported that the SCO-induced dysregulation of cholinergic activity in the hippocampus leads to interference in processes of learning and memory in mice ( 3 5 ).…”
Section: Introductionmentioning
confidence: 99%